GGT and ALT levels have been well accepted as important variables for screening NAFLD because both indicators are tested using a simple routine method in clinical or epidemiologic settings [7, 29, 30]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.